April 30, 2015
A majority of consumers are willing to take greater ownership of their health, according to a survey of 2,024 US adults and 516 primary care physicians.
The survey was conducted by Ipsos in collaboration with the National Council on Patient Information and Education (NCPIE) and Pfizer.
The survey found that 64 percent of respondents said they could be making more decisions about their health and...
April 16, 2015
New Jersey's Division of Consumer Affairs has launched a new app for iPhones that will allow authorized users of the state’s prescription monitoring program, prescribers and pharmacists licensed in New Jersey, access to the database via their smartphone.
The database is managed by the New Jersey Prescription Management Program (NJPMP), a program under the Division of Consumer Affairs. The NJPMP...
April 15, 2015
Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen.
The PatientsLikeMe-AstraZeneca deal is similar to one the company struck with Genentech last Spring. AstraZeneca will have full access to PatientsLikeMe's...
April 14, 2015
IBM Watson has taken a giant step deeper into the healthcare industry with the formation of a new business unit called Watson Health and a new cloud offering called the Watson Health Cloud. The move also includes some big name partners -- Apple, Johnson and Johnson, and Medtronic -- and two acquisitions: Cleveland-based Explorys and Dallas-based Phytel.
Watson has been involved in healthcare...
April 13, 2015
Since Walgreens merged with UK drugstore chain Boots last year, the company has been ramping up its digital strategy and has announced a slew of strategic partnerships with companies like Qualcomm Life, WebMD, MDLive, and PatientsLikeMe. Walgreens President and Walgreens Boots Alliance EVP Alex Gourlay, who transitioned over from Boots in the merger, spoke at HIMSS this week in Chicago about each...
April 9, 2015
In March, Roche received FDA clearance for its Accu-Chek Connect companion app, and, less than a month later, issued a recall of that app. App recalls, which are becoming more common as more and more apps receive FDA clearance, are less severe than device recalls because they can often be ameliorated with a quick software patch.
The app, available only on Android at present, helps patients track...
April 8, 2015
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower.
The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
April 6, 2015
When pharma-focused mobile clinical trial data collection company Clinical Ink and CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient engagement,merged last month, at least $9.8 million in equity and stock was exchanged as part of the merger, according to an SEC filing. According to the filing, some of that money went to the acquired company's...
April 6, 2015
Misfit Flash, one of the devices that will be used in the study.
AARP has launched a new research initiative, called Project Catalyst, where the organization will work with partners including Pfizer, UnitedHealthcare, and Georgia Tech to promote an increased focus on users over 50 in digital health research and development. The first project of the new initiative, focused on sleep and activity...
March 27, 2015
For the more than six years that MobiHealthNews has been covering the world of mobile and digital health pharma has always been one group that seemed just ready to break in. While providers and even payors have publicly gotten their hands dirty experimenting with telemedicine, remote patient monitoring, and patient engagement apps, pharma has largely been moving in the shadows through investments...